Mr Alan Reid

Mr Alan Reid


  • Principal Clinical Scientist within the Biochemistry Department, Queen Elizabeth University Hospital, NHS Greater Glasgow & Clyde.
  • Scheme Organiser of UK NEQAS Cardiac Marker Service
  • Executive Board Divisional Representative for Chemistry Division Currently
  • Treasurer of UK NEQAS


  • Research interests in the use of cardiac biomarkers in acute coronary syndrome and heart failure. From 1997 became interested in the development of cardiac marker EQA.
  • Continuing to develop EQA schemes for both laboratory and point of care systems with current and future cardiac biomarkers.
  • Developing current interpretative exercises to assist in clinical interpretation of cardiac biomarker testing
  • Was Specialist Committee Member of NICE Guidance(DG15): Myocardial infarction (acute): Early rule out using high-sensitivity troponin tests (Elecsys Troponin T high-sensitive, ARCHITECT STAT High Sensitive Troponin-I and AccuTnI+3 assays)


  • High-sensitivity cardiac troponin and the under diagnosis of myocardial infarction in woman: a prospective cohort study. BMJ 2015; 350 doi:
  • High-sensitivity cardiac troponin I at presentation in patients with suspected acute coronary syndrome: a cohort study. Lancet 2015; 386 DOI:


  • Organiser of the Cardiac Marker Dialogues, an international meeting on cardiac biomarkers.
  • Member of the Association of Clinical Biochemistry and the American Association of Clinical Chemistry.
  • Member of HighSTEACS study group looking at high sensitivity Troponin I in the evaluation of patients with Acute Coronary Syndrome in 10 hospitals in NHS Lothian and NHS Greater Glasgow and Clyde.
  • Currently a member of a group developing a candidate liquid chromatography mass spectrometry reference method for the quantification of the cardiac marker 1-32 B-type Natriuretic Peptide